CoChat
Sign Up
Cited by 170

The DOI matches its Crossref record.

Viable Mouse Models of Acid β-Glucosidase Deficiency

Xu, You-Hai, Quinn, Brian, Witte, David, Grabowski, Gregory A.·2003·The American Journal of Pathology
DOI 10.1016/s0002-9440(10)63566-3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)63566-3

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 41

  1. Blom, 1983, Gaucher disease–Norrbottnian type: neurodevelopmental, neurological, and neurophysiological aspects, Eur J Pediatr, 140, 316, 10.1007/BF00442672 · DOI
  2. Kolodny, 1982, Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients, Prog Clin Biol Res, 95, 33
  3. Volk, 1967, Infantile Gaucher's disease: electron microscopic and histochemical studies of a cerebral biopsy, J Neuropathol Exp Neurol, 26, 176
  4. Adachi, 1967, Fine structure of central nervous system in early infantile Gaucher's disease, Arch Pathol (Chicago), 83, 513
  5. Charrow, 2000, The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease, Arch Intern Med, 160, 2835, 10.1001/archinte.160.18.2835 · DOI
  6. Sibille, 1993, Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications, Am J Hum Genet, 52, 1094
  7. Abrahamov, 1995, Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype, Lancet, 346, 1000, 10.1016/S0140-6736(95)91688-1 · DOI
  8. Theophilus, 1989, Gaucher disease: molecular heterogeneity and phenotype-genotype correlations, Am J Hum Genet, 45, 212
  9. Theophilus, 1989, Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid β-glucosidase gene, Nucleic Acids Res, 17, 7707, 10.1093/nar/17.19.7707 · DOI
  10. Grace, 1994, Analysis of human acid β-glucosidase by site-directed mutagenesis and heterologous expression, J Biol Chem, 269, 2283, 10.1016/S0021-9258(17)42166-1 · DOI
  11. Sidransky, 1996, The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease, J Med Genet, 33, 132, 10.1136/jmg.33.2.132 · DOI
  12. Finn, 2000, Severe type II Gaucher disease with ichthyosis, arthrogryposis, and neuronal apoptosis: molecular and pathological analyses, Am J Med Genet, 91, 222, 10.1002/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-# · DOI
  13. Tayebi, 1997, Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene, Am J Med Genet, 73, 41, 10.1002/(SICI)1096-8628(19971128)73:1<41::AID-AJMG9>3.0.CO;2-S · DOI
  14. Tybulewicz, 1992, Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene, Nature, 357, 407, 10.1038/357407a0 · DOI
  15. Liu, 1998, Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure, Proc Natl Acad Sci USA, 95, 2503, 10.1073/pnas.95.5.2503 · DOI
  16. Kyle, 1990, Correction of murine mucopolysaccharidosis VII by a human β-glucuronidase transgene, Proc Natl Acad Sci USA, 87, 3914, 10.1073/pnas.87.10.3914 · DOI
  17. Vogler, 1990, A murine model of mucopolysaccharidosis VII: gross and microscopic findings in β-glucuronidase-deficient mice, Am J Pathol, 136, 207
  18. Sands, 1993, Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates, Lab Invest, 68, 676
  19. Clarke, 1997, Murine mucopolysaccharidosis type I: targeted disruption of the murine α-L-iduronidase gene, Hum Mol Genet, 6, 503, 10.1093/hmg/6.4.503 · DOI
  20. de Geest, 2002, Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice, Hum Mol Genet, 11, 1455, 10.1093/hmg/11.12.1455 · DOI · Paper page
  21. Marathe, 2000, Hum Mol Genet, 9, 1967, 10.1093/hmg/9.13.1967 · DOI
  22. Li, 2002, Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes, Genomics, 79, 218, 10.1006/geno.2002.6686 · DOI
  23. Dahl, 1990, Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene, Am J Hum Genet, 47, 275
  24. Lewis, 1994, Mutation analysis of 28 Gaucher disease patients: the australasian experience, Am J Med Genet, 49, 218, 10.1002/ajmg.1320490212 · DOI
  25. O'Neill, 1989, Comparison of the chromosomal localization of murine and human glucocerebrosidase genes and of the deduced amino acid sequences, Proc Natl Acad Sci USA, 86, 5049, 10.1073/pnas.86.13.5049 · DOI
  26. Sabath, 1990, Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte, Gene, 91, 185, 10.1016/0378-1119(90)90087-8 · DOI
  27. Fabbro, 1987, Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting, Am J Hum Genet, 40, 15
  28. O'Reilly, 1992
  29. Grabowski, 1986, Human acid β-glucosidase: use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes, J Biol Chem, 261, 8263, 10.1016/S0021-9258(19)83905-4 · DOI
  30. Fujita, 1996, Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids, Hum Mol Genet, 5, 711, 10.1093/hmg/5.6.711 · DOI
  31. Wells, 1963, The use of Sephadex for the removal of non-lipid contaminants from lipid extracts, Biochemistry, 2, 1259, 10.1021/bi00906a015 · DOI
  32. Dreyfus, 1997, Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples, Anal Biochem, 249, 67, 10.1006/abio.1997.2143 · DOI
  33. Igisu, 1983, Abnormal accumulation of galactosylceramide in the kidney of twitcher mouse, Biochem Biophys Res Commun, 110, 940, 10.1016/0006-291X(83)91053-7 · DOI
  34. Daniels, 1982, Brain glucocerebrosidase in Gaucher's disease, Arch Neurol, 39, 550, 10.1001/archneur.1982.00510210020005 · DOI
  35. Mizukami, 2002, Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage, J Clin Invest, 109, 1215, 10.1172/JCI0214530 · DOI
  36. Sauer, 1998, Inducible gene targeting in mice using the Cre/lox system, Methods, 14, 381, 10.1006/meth.1998.0593 · DOI
  37. Conzelmann, 1983, Partial enzyme deficiencies: residual activities and the development of neurological disorders, Dev Neurosci, 6, 58, 10.1159/000112332 · DOI
  38. Svennerholm, 1982, Chemical differentiation of the Gaucher subtypes, Prog Clin Biol Res, 95, 231
  39. Conradi, 1984, Neuropathology of the Norrbottnian type of Gaucher disease: morphological and biochemical studies, Acta Neuropathol (Berl), 65, 99, 10.1007/BF00690463 · DOI
  40. Pasmanik-Chor, 1996, The glucocerebrosidase D409H mutation in Gaucher disease, Biochem Mol Med, 59, 125, 10.1006/bmme.1996.0077 · DOI
  41. Latham, 1991, Heterogeneity of mutations in the acid β-glucosidase gene of Gaucher disease patients, DNA Cell Biol, 10, 15, 10.1089/dna.1991.10.15 · DOI

Cited by

See all 170

Metadata

Authors
Xu, Y.-H., Quinn, B., Witte, D., & Grabowski, G. A.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2003-11
Volume
163
Issue
5
Pages
2093-2101
ISSN
0002-9440
DOI
10.1016/s0002-9440(10)63566-3
Cited by
170
References
0
Language
en
Licence
Funders
National Institutes of Health (DK 36729)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Viable Mouse Models of Acid β-Glucosidase Deficiency. https://app.cochat.ai/papers/10.1016/s0002-9440(10)63566-3
The paper
Xu, Y.-H., Quinn, B., Witte, D., & Grabowski, G. A. (2003). Viable Mouse Models of Acid β-Glucosidase Deficiency. The American Journal of Pathology. https://doi.org/10.1016/s0002-9440(10)63566-3